Among children with intermediate-risk rhabdomyosarcoma that is negative for a fusion gene, those who had a high score of a specific gene signature called MG5 had poorer survival outcomes compared with those who had a low score of MG5, report researchers.
http://www.sciencedaily.com/releases/2015/10/151015083401.htm
Gene signature may help predict survival outcomes for some children with rhabdomyosarcoma
15 octubre 2015
Volver